House Committee Opens Inquiry Into Scientific Disagreements at the FDA

How the FDA handles internal scientific disagreements and whether scientists have faced retaliation for expressing differing scientific views is the subject of a letter sent by the House Energy and Commerce Committee to the FDA.
Source: Drug Industry Daily